Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses

Blood

Volumn 103, Issue 1, 2004, Pages 291-300

  Stankovic, Tatjana ^a   Hubank, Mike ^b   Cronin, Debbie ^b   Stewart, Grant S ^b   Fletcher, Danielle ^b   Bignell, Colin R ^b   Alvi, Azra J ^b   Austen, Belinda ^b   Weston, Victoria J ^b   Fegan, Christopher ^b   Byrd, Philip J ^b   Moss, Paul A H ^b   Malcolm, R Taylor A ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ADULT; APOPTOSIS; ARTICLE; ATM GENE; B CELL LEUKEMIA; CELL SURVIVAL; CLINICAL ARTICLE; DNA DAMAGE; DNA FINGERPRINTING; DNA MICROARRAY; FEMALE; GENE; GENE INACTIVATION; GENETIC HETEROGENEITY; GENETIC MARKER; HUMAN; LIFE EXPECTANCY; LYMPHATIC LEUKEMIA; MALE; PRIORITY JOURNAL; SOMATIC MUTATION; TP53 GENE; TRANSCRIPTION REGULATION;

EID: 9144247813     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-04-1161     Document Type: Article

References (54)

1. Caligaris CF. Biology of chronic lymphocytic leukaemia. Rev Clin Exp Haematol. 2000;4:5-21.
2. H genes are associated with a more aggressive form of chronic lymphocytic leukaemia. Blood. 1999;94:1848-1854.
3. Damle RN, Wasil T, Fats F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukaemia. Blood. 1999;94:1840-1847.
4. Lin K, Sherrington PD, Dennis M, Matrai Z, Cawley JC, Pettitt AR. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood. 2002;100:1404-1409.
5. Khanna KK, Jackson SP. DNA double-strand breaks: signalling, repair and the cancer connection. Nat Genet. 2001;3:247-254.
6. Kastan MB, Lim DC. The many substrates and functions of ATM. Nat Rev Mol Cell Biol. 2000;1:179-186.
7. Smith ML, Fornace AJ. Genomic instability and the role of p53 mutations in cancer cells. Curr Opin Oncol. 1995;7:69-75.
8. Cordone I, Masi S, Mauro FR, et al. p53 expression in B cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis. Blood. 1998;91:4342-4349.
9. Stankovic T, Weber P, Stewart G, et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet. 1999;353:26-29.
10. Pettitt AR, Sherrington PD, Stewart G, et al. p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood. 2001;98:814-822.
11. Stankovic T, Stewart GS, Fegan C, et al. Ataxia telanglectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood. 2002;99:300-309.
12. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194:1625-1638.
13. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639-1647.
14. Vallat L, Magdelenat H, Merle-Beral H, et al. The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays. Blood. 2003;10:4598-4606.
15. Kao LC, Germeyer A, Tulac S, et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology. 2003;144:2870-2881.
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289-300.
17. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863-14868.
18. Altman DG. Practical Statistics for Medical Research. London, England: Chapman & Hall; 1997.
19. Kellam P, Liu X, Martin N, Orengo C, Swift S, Tucker A. Comparing, contrasting and combining clusters in viral gene expression data. London, England: Proceedings of the 6th IDAMAP 2001 Workshop; 2001:56-62.
20. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer. 2002;2:420-430.
21. Boesen-deCock JGR, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gammaradiation downstream from caspase-8 activation. J Biol Chem. 1999;274:14255-14261.
22. Hwang PM, Bunz F, Yu J, et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med. 2001;7:1111-1117.
23. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 2001;7:683-694.
24. Kannan K, Amariglio N, Rechavi G, et al. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene. 2001;20:2225-2234.
25. Kassavetis GA, Grove A, Geiduschek EP. Effects of DNA strand breaks on transcription by RNA polymerase, III: insights into the role of TFIIIB and the polarity of promoter opening. EMBO J. 2002;21:5508-5515.
26. Paunesku T, Mittal S, Protic M, et al. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol. 2001;77:1007-1021.
27. Sun XH, Kincade PW. Gatekeeper mechanisms for immature B cells. Nat Immunol. 2002;3:898-899.
28. Fox EJ, Wright SC. S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells. Biochem J. 2001;359:361-367.
29. Leung SM, Hightower LE. A 16-kDa protein functions as a new regulatory protein for Hsc70 molecular chaperone and is identified as a member of the Nm23/nucleoside diphosphate kinase family. J Biol Chem. 1997;272:2607-2614.
30. Kimura N, Shimada N, Fukuda M, et al. Regulation of cellular functions by nucleoside diphosphate kinases in mammals. J Bioenerg Biomembr. 2002;32:309-315.
31. Elrod-Erickson MJ, Kaiser CA. Genes that control the fidelity of endoplasmic reticulum to Golgi transport identified as suppressors of vesicle budding mutations. Mol Biol Cell. 1996;7:1043-1058.
32. Kim CA, Phillips ML, Kim W, et al. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. EMBO J. 2001;20:4173-4182.
33. Linder P, Stutz F. mRNA export: travelling with DEAD box proteins. Curr Biol. 2001;11:R961-R963.
34. Wang JC. Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol. 2002;3:430-440.
35. Visser HP, Gunster MJ, Kluin-Nelemans HC, et al. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol. 2001;112:950-958.
36. Hoberf O, Westphal H. Functions of LIM-homeobox genes. Trends Genet. 2000;16:75-83.
37. Marecki S, Fenton MJ. The role of IRF-4 in transcriptional regulation. J Interferon Cytokine Res. 2002;2:121-133.
38. Ozato K, Tsujimura H, Tamura T. Toll-like receptor signalling and regulation of cytokine gene expression in the immune system. Biotechniques. 2002; (suppl):66-68, 70, 72.
39. He L, Liu J, Collins I, et al. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J. 2000;19:1034-1044.
40. Yu S, Asa SL, Ezzat S. Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary. Mol Endocrinol. 2002;16:1069-1078.
41. He YW, Orphan nuclear receptors in T lymphocyte development. J Leukoc Biol. 2002;72:440-446.
42. Bungert S, Molday LL, Molday RS. Membrane topology of the ATP binding cassette transporter ABCR and its relationship to ABC1 and related ABCA transporters: identification of N-linked glycosylation sites. J Biol Chem. 2001;276:23539-23546.
43. Moorefield B, Greene EA, Reeder RH. RNA polymerase I transcription factor Rrn3 is functionally conserved between yeast and human. Proc Natl Acad Sci U S A. 2000;97:4724-4729.
44. Lloyd AC. p53: only ARF the story. Nat Cell Biol. 2000;3:E48-E50.
45. Kulyte A, Navakauskiene R, Treigyte G, Gineitis A, Bergman T, Magnusson KE. Characterization of human a-dystrobrevin isoforms in HL-60 human promyelocytic leukemia cells undergoing granulocytic differentiation. Mol Biol Cell. 2002;12:4195-4205.
46. Ge Y, Wang X, Chen Z, Landman N, Lo EH, Kang JX. Gene transfer of the Caenorhabditis elegans n-3 fatty acid desaturase inhibits neuronal apoptosis. J Neurochem. 2002;82:1360-1366.
47. Yeoh E, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1:133-143.
48. Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75-87.
49. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277-288.
50. Westphal CH, Rowan S, Schmaltz C, Elson A, Fisher DE, Leder P. Atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet. 1997;16:397-401.
51. Khanna KK, Lavin MF, Jackson SP, Mulhern TD. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 2001;8:1052-1065.
52. Kassem HS, Sangar V, Cowan R, Clarke N, Margison GP. A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer. Int J Cancer. 2002;101:454-460.
53. Jung M, Dritschilo A. NF-kappa B signaling pathway as a target for human tumor radiosensitization. Semin Radiat Oncol. 2001;11:346-351.
54. Fan Z, Chakravarty P, Alfieri A, Pandita TK, Vikram B, Guha C. Adenovirus-mediated antisense ATM gene transfer sensitizes prostate cancer cells to radiation. Cancer Gene Ther. 2000;7:1307-1314.